Clinical Trial

Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated November 8, 2024 (before its estimated March 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Treatment of dermatophyte infection in our country (Pakistan) is becoming difficult due to the developing resistance to traditional antifungal agents. Assessing the effectiveness ,feasibility and standard dosage of a newer antifungal drug like voriconazole is the need of the hour in resistant cases of dermatophyte infection.
Trial Details
NCT Number NCT06680544
Lead Sponsor Sheikh Zayed Medical College
Conditions Dermatophyte Infection
Enrollment 120 participants
Start Date 2024-11-15
Primary Completion 2025-03-01 (estimated)
Study Completion 2025-03-15 (estimated)
Updated on ClinicalTrials.gov 2024-11-08